Probelte Pharma, S.A., started its activity in January 1996 as a manufacturer and marketer of allergy vaccines for human use, as part of the Probelte group of companies, well-established in the Spanish chemical industry.
At the moment, there are two main research lines in Probelte Pharma, S.A.:
-Manufacture and marketing of allergy vaccines, bacterial suspensions and autovaccines.
-Research and development for the biotechnology manufacture of new vaccines, which are safer and more effective.

The Production Laboratory of Probelte Pharma, S.A., has been designed using the most modern technologies and European requirements regarding sterile medicine facilities. Moreover, working in these facilities is a highly qualified team whose knowledge is constantly updated for improvement and adaptation to GMP standards.

Probelte Pharma, S.A. is especially interested in research and development in the field of Biotechnology to offer safer and more effective products to treat the corresponding pathologies.

• Inmaculada Espinosa